CLOSED
ACCREDITED INVESTORS ONLY
Invest in Fibrobiologics
The Future of Cell Therapy
This Reg D 506(c) offering is made available through StartEngine Primary, LLC, and the securities are being offered and sold only to accredited investors through general solicitation. This investment is speculative, illiquid, and involves a high degree of risk, including the possible loss of your entire investment.
